In the first head-to-head trial of its kind, people with obesity who took tirzepatide (sold under the brand names Mounjaro and Zepbound) lost more weight and inches from their waist than those who took semaglutide (Ozempic,

Fact checked by Nick Blackmer Tirzepatide and semaglutide, the ingredients in popular weight loss drugs, can both cause side effects, such as nausea, vomiting, and diarrhea.One is not safer than the other—tolerance to the medications largely depends on the patient.

Improvements with GLP-1 RAs in psoriasis and other chronic skin diseases point to their increased use in dermatology and a potential role for dermatologists in obesity management.

WGN’s Dina Bair has the latest on new medical information, including: Study: Mounjaro helped people achieve more weight loss than Ozempic In the first head-to-head study,

Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.

Ohio Attorney General Dave Yost sent letters to 14 medical spas warning them to stop making false or misleading claims about their versions of weight-loss drugs like Ozempic, Wegovy and Mounjaro. These medical spas were offering compounded versions of GLP-1s,

Often used as a weight-loss treatment, drugs such as Wegovy and Mounjaro have helped more than 500,000 people shed the extra pounds. The medications, known as semaglutides, predominantly treat diabetes but are also available on the NHS or via private providers to help adults with a high body mass index (BMI).

The 25-year-old, addressing critics who claim she has body dysmorphia, said, “People who are telling me that I don’t need to be on it, they don’t know what they’re talking about.” Sophia Umansky is addressing criticism over her decision to use a weight loss drug.